Medical News

RSS

FEI announces the sale of a complete correlative workflow to the University of Maastricht

FEI (NASDAQ: FEIC) announces the sale of a complete correlative workflow to the University of Maastricht. The systems will be installed at the University’s Institute of Nanoscopy, a new research facility that will use the high-resolution microscopes to understand the working mechanisms of protein complexes in an effort to develop new and improved treatment and prevention for disease, such as cancer and tuberculosis.

23 Jun 2014

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

Complementary medicines are generally being defined as medicines which are non-mainstream medicines and are mostly given together with conventional medicines.

23 Jun 2014

Aradigm begins Pulmaquin Phase III study for treatment of non-CF BE

Aradigm Corporation ("Aradigm" or the "Company") today announced the dosing of the first patient in the ORBIT-4 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) Phase III pivotal clinical trial of Aradigm's proprietary formulation of inhaled ciprofloxacin (Pulmaquin®) for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE).

23 Jun 2014

PSI CRO presents the changing dynamic of clinical trial feasibility at PCMG meeting

PSI CRO, a full-service contract research organization, announced today that Kasia Moscicka, Director Feasibility Research and Patient Recruitment Services, presented on the changing dynamic of clinical trial feasibility at recent PCMG meeting held in Lisbon, Portugal.

23 Jun 2014

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today it has in-licensed BL-1110, a novel compound for the treatment of neuropathic pain.

23 Jun 2014

Trevena reports positive results from TRV734 Phase 1 trial for treating acute/chronic pain

Trevena, Inc. (NASDAQ:TRVN) today announced positive results from its Phase 1 trial of TRV734, which Trevena is developing with the goal of providing improved analgesia while avoiding gastrointestinal and respiratory side effects typically associated with opioids.

23 Jun 2014

First Edition: June 23, 2014

Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.

23 Jun 2014

Cincinnati Children’s, Alexion Pharmaceuticals establish ‘Rare Disease Innovation Fund’

Alexion Pharmaceuticals, Inc. and Cincinnati Children's Hospital Medical Center today announced the establishment of a collaboration and fund for the advancement of research in rare disease.

23 Jun 2014

Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A

Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.

23 Jun 2014

eHealth interventions may help prevent HIV infection in high-risk men

While many HIV prevention interventions have traditionally been delivered face-to-face, a study from Columbia University School of Nursing suggests that digital outreach efforts delivered via text messages, interactive games, chat rooms, and social networks may be an effective way to reach at-risk younger men.

23 Jun 2014

USDM, DocuSign partner to help life science companies manage regulated business process

DocuSign, Inc. (DocuSign®) and USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, today announced a new partnership to help organizations automate regulated business processes for dramatic ROI, increased security and compliance, and faster speed to market.

23 Jun 2014

Physician describes ways to combat post-cancer pain

More and more people are surviving their cancer. Unfortunately, sometimes survival can come with pain. Although many people won't feel any pain after their cancer treatment, some may have chronic, bothersome pain.

23 Jun 2014

Clovis Oncology begins TIGER2 study for treatment of NSCLC patients with EGFR/T790M mutations

Clovis Oncology, Inc. announced today that the TIGER2 study has commenced with the dosing of the first patient at a U.S. study site.

23 Jun 2014

New concept of organs on a chip may help study cancer metastasis

The recent development of the concept of organs on a chip opens the possibility of realistically studying human organs without the use of patients or animal testing.

23 Jun 2014

Dimension Therapeutics closes $30M financing to advance novel gene therapy programs

Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.

23 Jun 2014

3M and Nextgen Healthcare partner to offer web-based ICD-10 Education Program

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today it has teamed with 3M Health Information Systems to offer 3M's robust, web-based ICD-10 Education Program industry wide.

23 Jun 2014

A new breakthrough for treating nasopharyngeal carcinoma

A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore, National University Cancer Institute Singapore (NCIS) and National University Hospital Singapore (NUH), discovered a distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer, paving the way to developing novel therapies for this deadly disease.

23 Jun 2014

Study reveals that inflammasomes remain active even after cell death

Even after a cell dies, components of the immune system remain active and continue to fuel inflammatory reactions.

23 Jun 2014

NCL collaborates with PeptiMed to evaluate safety and efficacy of nanocomplex materials

PeptiMed announced today that under a Material Transfer Agreement it will collaborate with the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), located at the Frederick National Laboratory of Cancer Research in Frederick, MD.

23 Jun 2014

Children of cancer patients show increased levels of emotional/behavioral problems

A cancer diagnosis affects the whole family, and a significant number of children of cancer patients may be at risk for emotional and behavioral problems.

23 Jun 2014

Medical News

FEI announces the sale of a complete correlative workflow to the University of Maastricht

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

Aradigm begins Pulmaquin Phase III study for treatment of non-CF BE

PSI CRO presents the changing dynamic of clinical trial feasibility at PCMG meeting

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

Trevena reports positive results from TRV734 Phase 1 trial for treating acute/chronic pain

First Edition: June 23, 2014

Cincinnati Children’s, Alexion Pharmaceuticals establish ‘Rare Disease Innovation Fund’

Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A

eHealth interventions may help prevent HIV infection in high-risk men

USDM, DocuSign partner to help life science companies manage regulated business process

Physician describes ways to combat post-cancer pain

Clovis Oncology begins TIGER2 study for treatment of NSCLC patients with EGFR/T790M mutations

New concept of organs on a chip may help study cancer metastasis

Dimension Therapeutics closes $30M financing to advance novel gene therapy programs

3M and Nextgen Healthcare partner to offer web-based ICD-10 Education Program

A new breakthrough for treating nasopharyngeal carcinoma

Study reveals that inflammasomes remain active even after cell death

NCL collaborates with PeptiMed to evaluate safety and efficacy of nanocomplex materials

Children of cancer patients show increased levels of emotional/behavioral problems

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News